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OBJECTIVE: Computed tomography-guided percutaneous fine needle aspiration biopsy of lung lesions is a simple, safe and 
reproducible procedure. Currently, it is widely used to diagnose lung lesions. However, different factors can influence the success 
rates of this procedure. The purpose of this study was to determine the influence of radiological and procedural characteristics in 
predicting the success rates of computed tomography-guided fine needle aspiration biopsy of lung lesions. 
SUBJECTS AND METHODS: A retrospective study was developed and involved 340 patients who were submitted to a consecu-
tive series of 362 computed tomography-guided fine needle aspiration biopsies of lung lesions, between July 1996 and June 2004, 
using 22-gauge needles (Chiba). Variables such as the radiological characteristics of the lesions, secondary pulmonary radiological 
findings, and procedural techniques were studied. 
RESULTS: For this study, 304 (84%) fine needle aspiration biopsies of lung lesions provided sufficient material for cytological 
evaluation. The variables that predicted sufficient material for cytological evaluation were lesions larger than 40 mm (p=0.02), 
lesions on the superior lung lobes (p=0.02), and suspicion of primary lung malignancy (p=0.03). From the multivariate analysis, 
the only predictive variable for success of the biopsies was localization on the superior lobes (p=0.01).
CONCLUSIONS: Computed tomography-guided percutaneous fine needle aspiration biopsy of lung lesions showed greater rates 
of success in biopsies performed in patients with suspicion of primary lung malignancy, with lesions located in the superior lobes, 
and that have diameters equal to and larger than 40 mm.
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INTRODUCTION
Computed tomography (CT)-guided percutaneous fine 
needle aspiration biopsy (FNAB) of lung lesions is currently 
one of the most commonly used techniques to determine the 
nature of lung lesions, such as nodules and tumors.1 Because 
it is a simple, safe and reproducible technique with lower 
costs than a surgical biopsy, it has been widely accepted.2-4
Significant variations in the accuracy of the procedure 
have been reported in the literature. Some studies had over 
90% accuracy. However, very few studies have examined the 
influence of the radiological characteristics of pulmonary 
lesions on the results of CT-guided FNAB.5-7
The purpose of this study was to evaluate the influence of 
radiological and procedural characteristics in predicting the 
success rates of CT-guided FNAB of lung lesions.
SUBJECTS AND METHODS
This is a retrospective analysis of all consecutive patients 
who were received CT-guided FNAB of pulmonary lesions 
at an oncological center in Brazil between 1996 and 2004.
From a total of 491 procedures evaluated, 362 (73.7%) 
were considered eligible for this study. Of the 129 excluded 
procedures, 6 (1.2%) were excluded because the lesions 
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were defined as being on the chest wall or pleura after 
cytological evaluation or on follow-up; 26 (5.3%) were 
excluded for having divergences between the admission and 
chart registrations; and 97 (19.8%) were excluded because 
the procedure was performed with cutting needles, which 
was not the subject of this study. A total of 362 procedures 
performed on 340 patients are reported. Of these 362 
procedures, 319 were of lesions submitted to biopsy once; 
20 were of lesions submitted to biopsy twice; and one was 
of a lesion submitted to biopsy three times. Written informed 
consent was obtained from all patients.
Information was collected from the charts available 
at the hospital’s Medical Archive Service (MAS) and the 
percutaneous biopsy forms. These forms contained data 
regarding the location, size of the lesions, distance between 
the lesion and the needle entrance site, the number of 
lesions, contour aspects of the lesions, and the relationship 
of the contour aspects to the adjacent structures such as the 
mediastinum or chest wall. Secondary radiological findings 
such as atelectasis, pleural effusion, cavitations, necrosis, 
infiltrates, adenopathy and the presence of other tumors were 
also included. Radiologic findings were based on the CT 
report prior to the procedure.
The FNABs were conducted by an oncologic radiologist 
with over ten years experience in CT-guided FNAB or by 
a resident in radiology under his guidance, following the 
standard procedure defined by the Imaging Department.8
At the Imaging Department, coagulation tests were 
routinely checked. When these tests were within normal 
parameters, the biopsy was planned and performed using a 
chest CT acquired with thin slices (3-5 mm). The computer’s 
cursor was used to measure the size of the lesions and the 
distances of the lesions from the biopsy needle entrance site. 
The skin was prepped with an antiseptic solution, and local 
anesthesia with 1% lidocaine was applied. The punction 
needle was introduced, and new tomographic cuts were 
obtained in order to confirm or modify the needle position. 
The biopsies were performed within a breath-hold.
The FNABs were performed using 22-gauge “CHIBA” 
type needles; subsequently, the obtained material was 
prepared in smears and immersed in 90% alcohol. Due to 
the retrospective nature of our study, it was not possible 
to determine the number of thoracic transfixations done 
by the FNAB procedure. However, the number of thoracic 
transfixations was indirectly obtained using the number 
of smears made by the puncture. In the experience of the 
Department of Imaging at the Hospital of Cancer, each 
puncture made around four smears.
The collected material was sent to the Department of 
Pathological Anatomy for analysis, where it was stained 
with hematoxylin-eosin (HE) and classified as adequate or 
inadequate for analysis, following department policy. When 
a sample was considered adequate by the pathologist, it was 
further categorized as positive, negative or suspicious for 
malignancy, and a specific diagnosis was provided when 
possible. For this study, we defined the FNAB as a success 
when the samples obtained were adequate for analysis by 
the pathologist.
The possible results included the following: malignant, 
when a specific type of cancer could be recognized; 
suspicion of malignancy, when atypical cells were present 
but were insufficient for a definitive diagnosis; negative for 
malignancy, when the sample was representative and without 
atypical cells; and possibly benign, when a benign tumor, 
inflammatory process or infection could be recognized. 
By correlating the patient radiological data with the 
sample analysis results and complications, we were able to 
determine the predictive success rates of CT-guided FNAB 
of lung lesions. Descriptive statistics were used when 
applied. The chi-square test or Fisher’s exact test was applied 
when appropriate. A P value was considered statistically 
significant when equal to or less than 0.05. The multivariable 
model of logistic regression analysis was applied using the 
variables that had p < 0.05 in univariate analysis; this model 
was used to identify possible predictive factors for the 
success of CT-guided FNAB. 
RESULTS
From the 362 FNABs performed, 212 (58.6%) were 
performed on male patients, and 150 (41.4%) were 
performed on female patients. The group mean age was 61 
± 16 years, and the median age was 63 years old. The reason 
for the FNAB referral was to obtain a primary diagnosis 
of a focal lesion suspected to be malignant in 215 (59.4%) 
procedures and to document possible secondary malignancy 
in 147 (40.6%) procedures. 
The lung lesions were right-sided in 163 (45%) 
procedures and left-sided in 154 (42.5%) procedures. The 
lesion distribution by pulmonary lobes was as follows: 
76 (21.0%) on the left superior lobe, 60 (16.6%) on the 
right superior lobe, 58 (16.0%) on the right inferior lobe, 
48 (13.3%) on the left inferior lobe, and 27 (7.5%) on the 
middle lobe. In addition, this information was not available 
in 93 cases (25.7%). 
The diameter of the lung lesions varied from 9 to 140 
mm (mean: 51.5 ± 24.3 mm; median: 40 mm). The distance 
between the lesion and the biopsy entry point on the skin 
varied from 10 to 130 mm (mean: 44 ± 20.9 mm; median: 
52 mm). Additionally, 71 (40.1%) lesions were in contact 
with the pleura, and 106 (59.9%) had pulmonary tissue 
positioned between the lesions and the pleura. The lesion 
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contour type was irregular in 96 patients (26.5%), spiculated 
in 38 patients (10.5%), smooth in 37 patients (10.2%), 
and lobulated in 22 patients (6.0%). This information was 
not available in 169 cases (46.8%). In 148 (40.9%) of the 
procedures, the patient had one lung lesion, and in 25 (6.9%) 
of the procedures, the patient had two lesions. In 22 (6.1%) 
of the procedures, the patients had three lesions, and in 43 
(11.9%) of the procedures, four or more lung lesions were 
present.
The most common secondary radiologic findings were 
adenopathy (34 patients; 9.4%), additional tumor (32 
patients; 8.8%), cavitation (16 patients; 4.4%), necrosis 
(14 patients; 3.9%), infiltration (13 patients; 3.3%), pleural 
effusion (10 patients; 2.8%), and opacification on the present 
lesion (four patients; 1.1%).
From a total of 362 needle biopsies, a cytological result 
was obtained from the patients’ charts for 357 (98.5%). The 
success rate for obtaining adequate material for cytological 
analysis is shown in table 1. 
Of the 357 punctions evaluated by the pathologist, 
the material was considered adequate for analysis in 304 
biopsies (84%) and inadequate for analysis in 53 biopsies 
(14.6 %) . 
The number of smears obtained per procedure varied 
from one to thirty-six (mean ± SD: 8.4 ± 5.7; median: 
7.0). Procedures that provided more than four smears had 
a proportionately larger amount of adequate material for 
analysis (88.1% vs. 78.5%; p = 0.04).
The proportion of biopsies with material judged adequate 
for analysis was higher in the patients referred for lesions 
suspected to be primary malignancy, as compared to the 
patients referred for lung lesions suspected to be secondary 
malignancy (Table 2). There was no difference in the 
material adequacy rate in patients of different gender or age 
groups (Table 2).
Table 3 shows the distribution of the radiological 
characteristics of the lesions and the corresponding rates of 
cytological material adequacy. The frequency of adequate 
material was higher in the lesions located in the superior 
lobes, as compared with the middle and inferior lobes. The 
larger lesion diameters (≥ 40 mm) also resulted in higher 
rates of success in obtaining adequate cytological material 
(Table 3). There was no statistical difference in material 
adequacy rates for series of biopsies performed in groups of 
patients with different secondary radiological lung findings. 
The total number of smears was not predictive of biopsy 
success.
In the multivariate analysis model, the only predictive 
variable for success of the biopsies was localization on the 
superior lobes (Table 4).
DISCUSSION
The overall success rate in our study was 84%, which 
is similar to other studies of FNAB of lung lesions without 
Table 1 - Cytological analysis results of 357 FNABs
Material n (%)
Adequate for Analysis
Malignant 204 56.4
Suspicion of malignancy 38 10.5
Negative for malignancy 45 12.4
Possibly Benign 17 4.7
Total 304 84.0
Inadequate for Analysis
Insufficient 44 12.1
Inadequate 9 2.5
Total 53 14.6
No information 5 1.4
Total 362 100
Table 2 - Material adequacy according to patient gender and age 
Variables n (%) Adequate Material n (%) Inadequate Material n (%) p
Gender 0.79
    Male 208 (58.2) 178 (85.6) 30 (14.4)
    Female 149 (41.8) 126 (84.6) 23 (15.4)
Age (mean) 0.07
     < 63 years 120 (48.8) 97 (80.8) 23 (19.2)
     ≥ 63 years 126 (51.2) 112 (88.9) 14 (11.1)
Clinical Suspicion 0.03
Primary malignancy 211 (59.1) 187 (89.0) 24 (11.0)
Secondary malignancy* 146 (40.9) 117 (80.1) 29 (19.9)
*Secondary malignancy – suspicion of metastatic disease related to a known neoplasm.
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Table 3 - Analysis of the radiological characteristics of the lung lesions in relation to the adequate and inadequate material
Variables n (%) Adequate Material  
n (%)
Inadequate Material 
n (%)
p
Contours 0.63
    Smooth 37 (19.2) 31 (83.8) 6 (16.2)
    Lobulated 22 (11.4) 21 (95.5) 1 (4.5)
    Spiculated 38 (19.7) 33 (86.8) 5 (13.2)
    Irreg. non-specif.*1 96 (49.7) 83 (86.5) 13 (13.5)
Width*2 0.23
    ≤52 mm 112 (49.3) 92 (82.1) 20 (17.9)
    >52 mm 115 (50.7) 101 (87.8) 14 (12.2)
Lung
    Right 161 (51.4) 138 (85.7) 23 (14.3) 0.49
    Left 152 (48.6) 126 (82.9) 26 (17.1)
Size*3
    <40 mm 138 (49.5) 110 (79.7) 28 (20.3) 0.02
    ≥40 mm 141 (50.5) 127 (90.1) 14 (9.9)
No. of Lesions 
    One 148 (62.1) 125 (85.0) 22 (15.0) 0.29
    Two 25 (10.5) 19 (76.0) 6 (24.0)
    Three 22 (9.2) 21 (95.5) 1 (4.5)
    Four or more 43 (18.2) 35 (81.4) 8 (18.6)
Lobes
    Superior 133 (49.5) 121 (91.0) 12 (9.0) 0.02
    Middle 30 (11.1) 23 (76.7) 7 (23.3)
    Inferior 106 (39.4) 84 (79.2) 22 (20.8)
Pleura Relation 0.49
   Yes 71 (40.1) 61 (85.9) 10 (14.1)
    No 106 (59.9) 87 (82.0) 19 (18)
Vital Organs*4 0.20
   Yes 33 (18.6) 30 (90.9) 3 (9.1)
   No 144 (81.4) 118 (84.9) 26 (18.1)
*1 Irreg. non-specif., when the contour of the pulmonary injury was classified as irregular by the radiologist without other specifica-
tions.
*2 Superficial, when less than or equal to medium size; deep, when larger than medium size.
*3 Smaller Size, when less than or equal to medium size; larger size, when larger than medium size.
*4 Vital Organs, when there is a relation to structures considered as vital: aorta, main bronchi, heart, pulmonary hilum, trachea, peri-
cardium, inferior vena cava, and pulmonary arteries and veins.
Table 4 - Multivariate model analysis for success in patients undergoing CT-guided FNAB of lung lesions 
Variables  95% Confidence Interval p
Odds Ratio Inferior Limit Superior Limit
Primary Diagnosis 1.99 0.87 4.55 0.10
Localization 3.37 1.36 8.35 <0.01
Size 0.44 0.19 1.01 0.05
Number of Smears 0.79 0.33 1.90 0.59
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immediate cytological examination.9-13  On univariate 
analysis, procedures that were able to provide more than four 
smears obtained a larger amount of adequate material for 
analysis when compared to the procedures that provided less 
than or equal to four smears. These results tend to support 
the recommendation of more than one chest transfixation 
by the FNAB procedure for thoracic lesions. Regarding the 
radiological characteristics, the lesions larger than 40 mm, 
those located in the superior lobes and suspicion of primary 
malignancy were predictive of the FNAB success.
Layfield et al. (1996) demonstrated that the localization 
and size of thoracic injuries affect the diagnostic accuracy 
of FNAB of the thorax, with the best results in peripheral 
and larger lesions.5 Yankelevitz et al. (1997), when studying 
small lesions (less or equal to 30 mm), demonstrated that 
the distance between the nodule and the pleural surface did 
not influence the biopsy accuracy.6 In our study, there was 
also no difference in obtaining adequate material for analysis 
between the superficial and deep lesions. 
Miller et al. (1998) demonstrated that spiculated contours 
and deep seated lesions were predictive characteristics of 
success in obtaining adequate material for analysis and 
diagnosis.7 In this study, we did not observe this relationship. 
Many authors have found larger amounts of adequate 
material for analysis and greater accuracy in the lesions that 
were considered large (greater than 1.5 cm) as compared 
with the lesions that were considered small.3,11,13-16 In this 
study, lesions with diameters equal to or larger than 40 mm 
supplied larger amounts of adequate material for analysis 
than lesions with diameters of less than 40 mm, and this 
difference was statistically significant.
In our study, we also observed that the location of the 
superior lobe lesions supplied a proportionally larger amount 
of adequate material for analysis when compared with other 
locations, and this difference was statistically significant. A 
possible explanation for this result is that it is often easier to 
reach the superior lobe injuries. Regardless of the position 
of the patient on the examination table, the punction needle 
generally reaches the injury at a straight angle. These lesions 
frequently have a pleural base and, consequently, a close-
fitting surface or even an infiltration of the chest wall, and 
this position favors the introduction of the needle to collect 
material for analysis without having to transpose the pleural 
space.
The patients who were referred due to suspicion of 
lung primary malignancy presented proportionally higher 
rates of adequate material for analysis in our study. One 
explanation for this finding could be the greater concern 
of the radiologist during the procedure for establishing a 
new cancer diagnosis rather than documenting a metastatic 
disease; however, this explanation is only an assumption.
Some lesion characteristics described in this study, 
such as the location on superior lobes and the suspicion of 
primary lung malignancy, were not described in previous 
studies. The only independent predictive factor of needle 
biopsy success was location in the superior lobes.
CONCLUSION
CT-guided percutaneous FNAB of lung lesions had 
a great rate of success in our study. Some radiologic 
characteristics of lung lesions may predict higher rates of 
success, such as a diameter equal to or larger than 40 mm, 
suspicion of primary lung malignancy, and location in the 
superior lobes. These characteristics should be considered 
when ordering this procedure.
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